Floatz logo

Dipeptiven

Coma

University of ZurichPhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Coma cohort.

Asset / SponsorPhaseRating
Keppra
University of North Carolina, Chapel Hill
Phase 4BB
Lacosamide
University of North Carolina, Chapel Hill
Phase 4BB
Valproic Acid
University of North Carolina, Chapel Hill
Phase 4BB
Fosphenytoin
University of North Carolina, Chapel Hill
Phase 4B
Baclofen
University Hospital, Bordeaux
Phase 2CCC
Phenobarbital
University of North Carolina, Chapel Hill
Phase 4CCC
Methylphenidate
Massachusetts General Hospital
Phase 1CC
Amantadine
Hamilton Health Sciences Corporation
N/AD

Same molecule, other indications

Dipeptiven is also rated in:

traumatic brain injuryDormant
B
Indicative ·
62 / 100
View asset →
gastric cancerDormant
B
Indicative ·
58 / 100
View asset →
pancreatic neoplasmDormant
B
Indicative ·
56 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →